Figure 3
Figure 3. The various effects of PolyP on blood clotting are strikingly dependent on polymer length. Specific activities of polyP are plotted versus polyP polymer lengths, normalized in each case to 100% maximal activity. The data are replotted from Smith et al27 (but on linear axes) for: (A) triggering of plasma clotting via the contact pathway, (B) modulating fibrin clot turbidity, (C) accelerating factor V activation, and (D) abrogating TFPI anticoagulant function; and from Choi et al29 for (E) promoting factor XI back-activation by thrombin. (E) polyP longer than 350 mers was not tested. In each panel, the pink bar represents the approximate size of polyP secreted from activated human platelets (∼ 60 to ∼ 100 mers),8,25,27 and yellow rectangle, the approximate size of microbial polyphosphate (ranging from < 100 mers to > 1500 mers).27

The various effects of PolyP on blood clotting are strikingly dependent on polymer length. Specific activities of polyP are plotted versus polyP polymer lengths, normalized in each case to 100% maximal activity. The data are replotted from Smith et al27  (but on linear axes) for: (A) triggering of plasma clotting via the contact pathway, (B) modulating fibrin clot turbidity, (C) accelerating factor V activation, and (D) abrogating TFPI anticoagulant function; and from Choi et al29  for (E) promoting factor XI back-activation by thrombin. (E) polyP longer than 350 mers was not tested. In each panel, the pink bar represents the approximate size of polyP secreted from activated human platelets (∼ 60 to ∼ 100 mers),8,25,27  and yellow rectangle, the approximate size of microbial polyphosphate (ranging from < 100 mers to > 1500 mers).27 

Close Modal

or Create an Account

Close Modal
Close Modal